XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Total operating revenues $ 4,060 $ 232
Operating expenses:    
Cost of production 4,425 3,090
Depreciation and amortization 4,575 1,442
Research and development expense 1,198 1,192
General and administrative expense 10,761 9,367
Project development costs 2,959 1,096
Facility idling costs 999 0
Total operating expenses 24,917 16,187
Loss from operations (20,857) (15,955)
Other income (expense)    
Interest expense (539) (2)
Investment income 3,067 252
Other income, net 711 32
Total other income, net 3,239 282
Net loss $ (17,618) $ (15,673)
Net loss per share - basic (in dollars per share) $ (0.07) $ (0.08)
Net loss per share - diluted (in dollars per share) $ (0.07) $ (0.08)
Weighted-average number of common shares outstanding - basic (in shares) 237,260,681 201,925,747
Weighted-average number of common shares outstanding - diluted (in shares) 237,260,681 201,925,747